Like this story, share it with millions of investors on M3
A tale of 2 pharma companies: Aurobindo shines, Sun Coughs
Traders cheered Aurobindo’s in-line performance by sending the stock nearly 4 percent higher. But they punished Sun Pharma for missing Street estimates across the board by sending the stock down over 6 percent. CNBC-TV18’s Ekta Batra and Archana Shukla crunch the numbers.